2025
SJR Q1
JCR Q2 · 3,3
OA
4 matched articles
ESCI
Journal detail
Animal Models and Experimental Medicine
- Publisher
- John Wiley and Sons Inc
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
2096545125762095
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,082
- Quartile Q1
- H-Index 36
- Cites/doc 3,82
- Docs (3y) 219
- Cites (3y) 911
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,3
- 5Y JIF 4,4
- JCI 0,53
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Biochemistry Q2
- Medical Laboratory Technology Q1
- Medicine (miscellaneous) Q1
- Molecular Biology Q2
- Veterinary (miscellaneous) Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Health Professions
- Medicine
- Veterinary
WoS categories
- Biochemistry & Molecular Biology | Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,082 | 3,3 | 4,4 | 0,53 | Q3 | 36 |
| 2024 | Q1 | Q2 | 1,167 | 3,4 | 3,8 | 0,6 | Q3 | 33 |
| 2023 | Q1 | Q2 | 1,026 | 3,8 | 3,5 | 0,68 | Q2 | 33 |
| 2022 | — | — | — | 3,7 | 3,7 | 0,64 | Q2 | 33 |
| 2021 | — | — | — | — | — | 0,66 | Q2 | 33 |
| 2020 | — | — | — | — | — | — | — | 33 |
| 2019 | — | — | — | — | — | — | — | 33 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | Q3 | Q3 | 178/328 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q2 | Q3 | 86/191 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | Q2 | Q3 | 138/320 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q2 | Q3 | 75/195 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | Q2 | Q2 | 114/313 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | Q2 | Q2 | 67/189 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | — | Q3 | — |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q2 | — |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCI | — | Q2 | — |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | ESCI | — | Q2 | — |